Skip to Main Content

Paper Details

Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Ophthalmology
109
2018
AMD, APOE, AREDS2, ARMS2, Age-Related Eye Disease, Age-related Macular Degeneration, C3, GA, Geographic Atrophy, PARTICIPANTS, age-related macular degeneration, genetic variants, geographic atrophy, neovascular AMD, neovascular disease, participants, vision loss
Aged, Aged, 80 and over, Disease Progression, Docosahexaenoic Acids, Drug Therapy, Combination, Eicosapentaenoic Acid, Female, Geographic Atrophy, Humans, Lutein, Macular Degeneration, Male, Middle Aged, Photography, Prospective Studies, Visual Acuity, Zeaxanthins
Author NameAffiliation
Tiarnan D L KeenanDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Elvira Agr??nDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Amitha DomalpallyThe University of Wisconsin
Traci E ClemonsThe Emmes Corporation
Freekje van AstenNational Eye Institute, National Institutes of Health
Wai T WongNational Eye Institute, National Institutes of Health
Ronald P DanisThe University of Wisconsin
SriniVas R SaddaDoheny Eye Institute
Philip J RosenfeldBascom Palmer Eye Institute, University of Miami Miller School of Medicine
Michael L KleinCasey Eye Institute, Oregon Devers Eye Clinic
Rinki RatnapriyaNational Eye Institute, National Institutes of Health
Anand SwaroopNational Eye Institute, National Institutes of Health
Frederick L FerrisDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health
  • 1 - 14

Datasets